An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma

Craig H. Moskowitz, Andrew Zelenetz, Heiko Schoder

Research output: Contribution to journalArticle

21 Scopus citations


A significant amount of literature is available on treatment monitoring and response assessment in lymphoma using FDG-PET, yet confusion exists concerning the potential and limitations of FDG-PET for determining the presence of residual disease during chemotherapy (interim FDG-PET). This article reviews the role of interim FDG-PET in 3 important scenarios: untreated diffuse large B-cell lymphoma, untreated Hodgkin lymphoma, and relapsed or refractory aggressive lymphoma in transplant-eligible patients, and provides recommendations on the use of this imaging modality in these settings.

Original languageEnglish (US)
Pages (from-to)347-352
Number of pages6
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number3
StatePublished - Mar 2010
Externally publishedYes



  • Diffuse large B-cell lymphoma
  • Hodgkin lymphoma
  • Interim FDG-PET
  • Stem cell transplantation

ASJC Scopus subject areas

  • Oncology

Cite this